Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
826.00    9.00 (1.10%)
Bid:
825.00
Ask:
827.00
Spread: 2.00 (0.242%)
Market Cap: £1.14b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

12 May 2014 11:02

RNS Number : 8360G
Savills PLC
12 May 2014
 



 

12 May 2014

 

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following Interim Management Statement (IMS) for the period to 12 May 2014.

 

During the first four months of the year Savills has traded as anticipated with continued growth in the UK, and a robust performance in both Asia and Continental Europe. Our US business has an improved pipeline and Cordea Savills, the Group's investment management business, has traded in line with our expectations of revenue and profit growth.

 

In the UK commercial markets Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although, as anticipated, the shortage of supply of investment stock has become increasingly apparent. Growth in investment volume outside London has continued from last year and development activity has further increased. We continue to expect regional recovery to be the primary driver of growth for our UK commercial business in 2014.

 

The UK Prime Residential market has continued to perform well with year on year increases in both volume and value. As anticipated, we have lately seen some cooling in the Prime and Super Prime Central London market. In contrast, there remains strong demand for property in the £1 million-£2 million price segments of the North, East and South West London regions. The regional UK residential market is continuing to recover with growing volumes and a significant increase in buyers registering with Savills.

 

In Asia Pacific, allowing for the material fall in trading volumes in Hong Kong in comparison with the same period last year, business has performed in line with expectations. Our Japanese business has continued to grow substantially as a result of the sustained strength of the Tokyo commercial investment market during the period. In mainland China, despite a slow down in transaction markets, revenue and earnings have grown in line with our expectations thanks to the growth of our Property Management business.

 

In Continental Europe, to date we have traded in line with our expectations, with strengthening performance in the transaction markets of Ireland, Spain, Germany and France.

 

Globally, our Consultancy business has experienced continued revenue growth with particular strengths in UK Development consultancy and UK/Continental European Valuation consultancy. The Property Management business has delivered a solid increase in revenue, particularly in the UK and in Asia where we continued to grow our market share in the core markets of Hong Kong and China.

 

Following a strong year of capital raising in 2013, Cordea Savills has grown revenue and profits in line with our expectations for the period to date, whilst continuing to experience significant capital inflows.

 

In the US, the existing Savills business has performed in line with expectations and our proposed acquisition of Studley Inc. was unanimously approved at the Studley Stockholder meeting held yesterday. Pending expiry of the Hart-Scott-Rodino Antitrust notification period, it is anticipated that the transaction will be completed on 30th May 2014.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAESAFEFLEFF
Date   Source Headline
14th Jan 20217:00 amRNSYear End Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20208:59 amRNSNon-executive Director changes
14th Dec 20209:45 amRNSDirector/PDMR Shareholding
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
3rd Nov 20202:26 pmRNSHolding(s) in Company
22nd Oct 20205:41 pmRNSHolding(s) in Company
13th Oct 20205:22 pmRNSDirector/PDMR Shareholding
1st Oct 202010:00 amRNSTotal Voting Rights
14th Sep 202011:05 amRNSDirector/PDMR Shareholding
2nd Sep 202010:41 amRNSHolding(s) in Company
13th Aug 20205:00 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNSHalf-year Report
4th Aug 20203:22 pmRNSTotal Voting Rights
21st Jul 202010:00 amRNSBlock listing Interim Review
13th Jul 20202:15 pmRNSHolding(s) in Company
13th Jul 202012:26 pmRNSDirector/PDMR Shareholding
6th Jul 202010:13 amRNSHolding(s) in Company
6th Jul 202010:09 amRNSHolding(s) in Company
1st Jul 20204:51 pmRNSDirector/PDMR Shareholding
1st Jul 202010:00 amRNSTotal Voting Rights
30th Jun 20204:52 pmRNSDirector/PDMR Shareholding
25th Jun 202011:27 amRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
11th Jun 202011:29 amRNSDirector/PDMR Shareholding
5th Jun 20201:03 pmRNSDirectors Remuneration Policy - Clarification
5th Jun 202012:42 pmRNSDirectors Remuneration Policy - Clarification
1st Jun 20207:00 amRNSTotal Voting Rights
12th May 202012:01 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 202012:15 pmRNSDisclosure of rights attached to equity shares
28th Apr 20203:53 pmRNSDirector/PDMR Shareholding
16th Apr 202011:56 amRNSDirector/PDMR Shareholding
6th Apr 202012:37 pmRNSAnnual Report and AGM Notice
1st Apr 20207:00 amRNS2020 AGM & 2019 final and supplemental dividends
1st Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20205:33 pmRNSDirector/PDMR Shareholding
20th Mar 20201:40 pmRNSDirector/PDMR Shareholding
13th Mar 20201:43 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results
11th Mar 20201:12 pmRNSDirector/PDMR Shareholding
26th Feb 202012:58 pmRNSHolding(s) in Company
17th Feb 20203:29 pmRNSBlock listing Interim Review
11th Feb 20205:00 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.